Physica Medica: European Journal of Medical Physics
Volume 26, Issue 2 , Pages 80-87 , April 2010

A dosimetric analysis comparing electron beam with the MammoSite brachytherapy applicator for intact breast boost

  • A.P. Shah

      Affiliations

    • Rush University Medical Center, Department of Radiation Oncology, 1653 West Congress Parkway, Chicago, IL 60612, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 312 942 5751; fax: +1 312 942 2339.
    • ,
  • J.B. Strauss

      Affiliations

    • Rush University Medical Center, Department of Radiation Oncology, 1653 West Congress Parkway, Chicago, IL 60612, United States
    • ,
  • M.C. Kirk

      Affiliations

    • Rush University Medical Center, Department of Radiation Oncology, 1653 West Congress Parkway, Chicago, IL 60612, United States
    • ,
  • S.S. Chen

      Affiliations

    • Rush University Medical Center, Department of Radiation Oncology, 1653 West Congress Parkway, Chicago, IL 60612, United States
    • ,
  • A. Dickler

      Affiliations

    • Little Company of Mary Hospital, Department of Radiation Oncology, Evergreen Park, IL 60805, United States

Received 14 January 2009 ,Revised 17 June 2009 ,Accepted 29 August 2009.

References 

  1. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–1232
  2. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;341:1233–1241
  3. Poggi MM, Danforth DN, Sciuto LC, Smith SL, Steinberg SM, Liewehr DJ, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy. Cancer. 2003;98:697–702
  4. Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 2001;345:1378–1387
  5. Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol. 2007;25:3259–3265
  6. Poortmans P, Bartelink H, Horiot JC, Struikmans H, Van den Bogaert W, Fourquet A, et al. The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ randomized trial. Radiother Oncol. 2004;72:25–33
  7. Denham JW, Rw Sillar, Clarke D. Boost dosage to the excision site following conservative surgery for breast cancer: it's easy to miss. Clin Oncol. 1991;3:257–261
  8. Hunter MA, McFall TA, Hehr KA. Breast conserving surgery for primary breast cancer: necessity for surgical clips to define the tumor bed for radiation planning. Radiology. 1996;200:281–282
  9. Benda RK, Yasuda G, Sethi A, Gabram SG, Hinerman RW, Mendenhall NP. Breast boost: are we missing the target?. Cancer. 2003;97:905–909
  10. Landis DM, Luo W, Song J, Bellon JR, Punglia RS, Wong JS, et al. Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity. Int J Radiat Oncol Biol Phys. 2007;67:1299–1308
  11. Li XA, Tai A, Arthur DW, Buchholz TA, Macdonald S, Marks LB, et al. Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG multi-institutional and multiobserver study. Int J Radiat Oncol Biol Phys. 2009;73:944–951
  12. Oh KS, Kong FM, Griffith KA, Yanke B, Pierce LJ. Planning the breast tumor bed boost: changes in the excision cavity volume and surgical scar location after breast-conserving surgery and whole-breast irradiation. Int J Radiat Oncol Biol Phys. 2006;66:680–686
  13. Jacobson G, Betts V, Smith B. Change in volume of lumpectomy cavity during externa-beam irradiation of the intact breast. Int J Radiat Oncol Biol Phys. 2006;65:1161–1164
  14. Resch A, Pötter R, Van Limbergen E, Biber E, Klein T, Fellner C, et al. Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer. Radiother Oncol. 2002;63:47–58
  15. Frazier RC, Kestin LL, Kini V, Martinez AA, Chen PY, Baglan KL, et al. Impact of boost technique on outcome in early-stage breast cancer patients treated with breast-conserving therapy. Am J Clin Oncol. 2001;24:26–32
  16. Moreno F, Guedea F, Lopez Y, Ferrer F, Gutierrez C, Petriz L, et al. External beam irradiation plus (192)Ir implant after breast-preserving surgery in women with early breast cancer. Int J Radiat Oncol Biol Phys. 2000;48:757–765
  17. Hennequin C, Durdux C, Espié M, Balla-Mekias S, Housset M, Marty M, et al. High-dose-rate brachytherapy for early breast cancer: an ambulatory technique. Int J Radiat Oncol Biol Phys. 1999;45:85–90
  18. Keisch M, Vicini F, Kuske R, et al. Two-year outcome with the MammoSite breast brachytherapy applicator: factors associated with optimal cosmetic outcome when performing partial breast irradiation. Int J Radiat Oncol Biol Phys. 2003;57:S311
  19. Keisch M, Vicini F, Kuske RR, Hebert M, White J, Quiet C, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;55:289–293
  20. Dowlatshahi K, Snider HC, Gittleman MA, Nguyen C, Vigneri PM, Franklin RL. Early experience with balloon brachytherapy for breast cancer. Arch Surg. 2004;139:603–608
  21. Richards GM, Berson AM, Rescigno J, Sanghavi S, Siegel B, Axelrod D, et al. Acute toxicity of high-dose-rate intracavitary with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol. 2004;11:739–746
  22. Dickler A, Kirk MC, Choo J, Hsi WC, Chu J, Dowlatshahi K, et al. Cosmetic outcome and incidence of infection with the MammoSite breast brachytherapy applicator. Breast J. 2005;5:306–310
  23. Niehoff P, Ballardini B, Polgár C, Major T, Hammer J, Richetti A, et al. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer. Breast. 2006;15:319–325
  24. Niehoff P, Polgár C, Ostertag H, Major T, Sulyok Z, Kimmig B, et al. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial. Radiother Oncol. 2006;79:316–320
  25. Dragun AE, Harper JL, Jenrette JM, Sinha D, Cole DJ. Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys. 2007;68:354–358
  26. Vicini FA, Beitsch P, Quiet C, Keleher A, Garcia D, Snide H, et al. Three-year analysis of treatment efficacy, cosmesis and toxicity by the American Society of Breast Surgeons (ASBS) MammoSite breast brachytherapy registry trial in patients treated with accelerated partial breast irradiation (APBI). Int J Radiat Oncol Biol Phys. 2007;69:S207
  27. Benitez PR, Keisch ME, Vicini F, Stolier A, Scroggins T, Walker A, et al. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg. 2007;194:456–462
  28. NSABP B-39/RTOG 0413 Protocol Document . National Surgical Adjuvant Breast and Bowel Project. https://members.nsabp.pitt.edu/B39_Protocol.pdfMarch 13, 2007;
  29. Dickler A, Kirk M, Choo J, Hsi WC, Chu J, Dowlatshahi K, et al. Treatment volume and dose optimization of the MammoSite breast brachytherapy applicator. Int J Radiat Oncol Biol Phys. 2004;59:469–474
  30. Romestaing P, Lehingue Y, Carrie C, Coquard R, Montbarbon X, Ardiet JM, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol. 1997;15:963–968

PII: S1120-1797(09)00052-0

doi: 10.1016/j.ejmp.2009.08.004

Physica Medica: European Journal of Medical Physics
Volume 26, Issue 2 , Pages 80-87 , April 2010

Article Tools

* Image Usage & Resolution